NCT05408364

Brief Summary

The aim of this study is to evaluate the clinical and microbiological effects of Bifidobacterium animalis subsp. lactis DN-173010 containing yoghurt as an adjunct to mechanical periodontal treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
9.1 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
Last Updated

June 7, 2022

Status Verified

March 1, 2011

Enrollment Period

2 years

First QC Date

May 16, 2022

Last Update Submit

June 2, 2022

Conditions

Keywords

bifidobacteriumchronic periodontitisdental scalingprobioticroot planing

Outcome Measures

Primary Outcomes (1)

  • Probing Depth

    Probing depth is defined as the distance from the free gingival margin to the bottom of the periodontal pocket.

    28 days

Secondary Outcomes (5)

  • Gingival Index

    28 days

  • Plaque Index

    28 days

  • Bleeding on probing

    28 days

  • Clinical attachment level

    28 days

  • microbiological parameters

    28 days

Study Arms (2)

Natural yoghurt

PLACEBO COMPARATOR

SRP+nature yogurt (Danone® yogurt, Luleburgaz, Türkiye)

Dietary Supplement: probiotic or natural yoghurtProcedure: SRP

Probiotic yoghurt

EXPERIMENTAL

SRP+probiotic containing yogurt (Danone Activia® Plain, Luleburgaz, Türkiye)

Dietary Supplement: probiotic or natural yoghurtProcedure: SRP

Interventions

Bifidobacterium animalis subsp. lactis DN-173010 containing probiotic yoghurt

Natural yoghurtProbiotic yoghurt
SRPPROCEDURE

Scalling and root planing

Natural yoghurtProbiotic yoghurt

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • chronic periodontitis patients with radiographically detected horizontal bone loss
  • the presence of at least 2 teeth with one approximal site with a probing pocket depth (PPD) of 4≤SD\<7 mm (5-7 mm) and a GI of ≥2 mm in each quadrant,
  • previously untreated periodontitis, systemically healthy

You may not qualify if:

  • Systemic diseases
  • Antibiotics and anti-inflammatory drugs within 3 months before the study
  • Untreated caries lesions or local retention factors
  • Allergic reactions to lactose or fermented milk products
  • Previous probiotic supplements in diet
  • Smoking
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, Maltepe, 34854, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Chronic Periodontitis

Interventions

Probiotics

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Bahar Kuru, Prof. Dr.

    Marmara University, Faculty of Dentistry, Department of Periodontology

    STUDY DIRECTOR
  • Hafize Öztürk Özener, Dr.

    Marmara University, Faculty of Dentistry, Department of Periodontology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Individuals and doctor were blinded to the study groups allocation. Before statistical analysis, the blind study coordinator broke the code to allocate the indivuals to the groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2022

First Posted

June 7, 2022

Study Start

April 1, 2011

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

June 7, 2022

Record last verified: 2011-03

Locations